DekaBank Deutsche Girozentrale
KRTX

DekaBank Deutsche Girozentrale’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$6.33M – 1530
2023
Q4 		$6.33M Buy
20,000
+1,510
+8% +$294K 0.01% 536
2023
Q3 		$3.11M Buy
18,490
+490
+3% +$92.1K 0.01% 642
2023
Q2 		$3.9M Hold
18,000
– – 0.01% 603
2023
Q1 		$3.24M Hold
18,000
– – 0.01% 628
2022
Q4 		$3.49M Hold
18,000
– – 0.01% 610
2022
Q3 		$4.08M Sell
18,000
-2,150
-11% -$435K 0.01% 561
2022
Q2 		$2.52M Buy
20,150
+10,500
+109% +$1.21M 0.01% 676
2022
Q1 		$1.19M Buy
9,650
+900
+10% +$101K ﹤0.01% 879
2021
Q4 		$1.15M Buy
8,750
+250
+3% +$32.3K ﹤0.01% 909
2021
Q3 		$1.01M Hold
8,500
– – ﹤0.01% 897
2021
Q2 		$946K Hold
8,500
– – ﹤0.01% 921
2021
Q1 		$993K Hold
8,500
– – ﹤0.01% 905
2020
Q4 		$867K Sell
8,500
-400
-4% -$37.1K ﹤0.01% 903
2020
Q3 		$703K Buy
+8,900
New +$758K ﹤0.01% 855

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

DekaBank Deutsche Girozentrale's KRTX Position: Q1 2024 in Review

DekaBank Deutsche Girozentrale sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 20,000 shares — an estimated $6.33M sold.

DekaBank Deutsche Girozentrale first reported a position in KRTX in Q3 2020 and held it in 14 quarters. The position peaked at $6.33M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • DekaBank Deutsche Girozentrale reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 20,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.33M.
  • DekaBank Deutsche Girozentrale first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • DekaBank Deutsche Girozentrale's Karuna Therapeutics, Inc. Common Stock position peaked at $6.33M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.